Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current therapies in the management of systolic and diastolic dysfunction.

Dimensions of critical care nursing : DCCN·2011
Same author

Homocysteine: the latest risk factor for heart disease.

Dimensions of critical care nursing : DCCN·2000
Same author

Beta-blocker therapy for secondary prevention of myocardial infarction.

Dimensions of critical care nursing : DCCN·2000
Same author

Angiotensin-converting enzyme inhibitors and left ventricular remodeling: implications for nurses.

Dimensions of critical care nursing : DCCN·2000
Same author

Caregiver burden: historical development.

Nursing forum·1999
Same author

Mycophenolate mofetil (CellCept): the newest immunosuppressant.

Critical care nurse·1998
Same journal

Section: Book and Media.

Dimensions of critical care nursing : DCCN·2026
Same journal

Exploring RN Resignation Experiences.

Dimensions of critical care nursing : DCCN·2026
Same journal

Nursing Perspectives on Glycemic Control for Critically Ill Adults in the Intensive Care Unit: A Narrative Review.

Dimensions of critical care nursing : DCCN·2026
Same journal

Quantitative Pupillometry Values Are Similar in Bright Light and Dim Light Conditions.

Dimensions of critical care nursing : DCCN·2026
Same journal

Intravenous Smart Pump Alarms in Everyday Hospital Use: A Real-world Descriptive Analysis.

Dimensions of critical care nursing : DCCN·2026
Same journal

The Trajectories of Platelet, Fibrinogen, and D-dimer in Severe Trauma Patients and Their Value in Predicting Venous Thromboembolism: A Retrospective Study.

Dimensions of critical care nursing : DCCN·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Beta-blocker therapy for hypertension.

S J Reeder1, R L Hoffmann

  • 1Villanova University School of Nursing, Villanova, PA, USA.

Dimensions of Critical Care Nursing : DCCN
|November 15, 2011
PubMed
Summary
This summary is machine-generated.

Hypertension increases the risk of serious diseases. Beta-blocker medications effectively lower blood pressure and prevent associated complications, aiding critical care decisions.

Related Experiment Videos

Last Updated: May 27, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Hypertension is a significant risk factor for severe health conditions, including heart disease, myocardial infarction, renal failure, and stroke.
  • Effective management of hypertension is crucial for mitigating its detrimental effects and preventing secondary complications.

Purpose of the Study:

  • To detail the pathophysiology and theories behind primary hypertension.
  • To outline the complications associated with hypertension.
  • To provide critical care nurses with information on beta-blocker therapy, including pharmacodynamics, recent research, and clinical decision-making.

Main Methods:

  • Literature review on hypertension pathophysiology and complications.
  • Analysis of beta-blocker mechanisms of action and clinical research.
  • Focus on critical care nursing implications for medication management.

Main Results:

  • Beta-blockers are effective in reducing blood pressure.
  • These medications help prevent adverse outcomes like ventricular remodeling, endothelial dysfunction, and renal insufficiency.
  • Understanding beta-blocker pharmacodynamics is key for critical care decision-making.

Conclusions:

  • Beta-blocker therapy is a vital component in managing hypertension and its complications.
  • Critical care nurses require updated knowledge on beta-blockers for optimal patient care.
  • Further research into beta-blocker therapy can enhance treatment strategies for hypertensive patients.